Arvinas price target lowered to $81 from $87 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $81 from $87 and keeps a Buy rating on the shares. Given the company’s ...
Sage Therapeutics price target lowered to $12 from $14 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Sage Therapeutics (SAGE) to $12 from $14 and keeps a Neutral rating on the shares. The ...
H.C. Wainwright lifts Coinbase stock target to $330 on crypto rally
H.C. Wainwright analyst Mike Colonnese increased the price target for Coinbase Global Inc. (NASDAQ:COIN) shares to $330, up from the previous $255, while maintaining a Buy rating on the stock. The ...
HC Wainwright Reiterates “Buy” Rating for 4D Molecular Therapeutics (NASDAQ:FDMT)
D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at ...
HC Wainwright Issues Pessimistic Forecast for XFOR Earnings
Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for X4 Pharmaceuticals in a research note issued on Friday, February 7th. HC Wainwright analyst S. Ramakanth now forecasts ...
BioSpace1h
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
Orion Energy projects $77M-$83M FY25 revenue with focus on LED and EV growth
Management lowered fiscal 2025 revenue guidance to $77M to $83M, reflecting timing changes in large projects. For Q4 2025, revenue is expected to range between $19M and $25M. Jenkins shared confidence ...
Tigo Energy projects 2025 revenues between $85M-$100M driven by growth in EMEA and Americas
Revenue for Q4 2024 was reported at $17.3 million, an 86.8% year-over-year increase and a 21.3% sequential rise. Regional contributions included EMEA at $11.2 million (65% of total revenue), Americas ...